Knife Juggling, Bottle Rockets, and Small Cap Investing
Motley Fool Money
00:00
Biotech and Travel: Market Insights
This chapter explores the current landscape of the SpaceTech and biotech sectors, specifically focusing on CRISPR technology and its FDA approval for sickle cell treatment. It contrasts investor sentiment with actual stock performance and highlights the unique market dynamics of the travel company Despegar in Latin America. The discussion also touches on the implications of hyperinflation in Argentina and the potential of small-cap stocks as investment opportunities.
Play episode from 13:44
Transcript
